In colorectal carcinoma, PERK signaling is crucial for the adaptation of cells to hypoxic stress [115], and activation of the PERK-eIF2α-ATF4 pathway is critical for promoting tumor dormancy, which contributes to chemoresistance in human epidermoid carcinoma cells [116]. Here, ATF4 is linked to neoplasm.